Protalix BioTherapeutics Inc (PLX)
1.11
-0.03
(-2.63%)
USD |
NYAM |
May 06, 16:00
1.11
0.00 (0.00%)
Pre-Market: 08:09
Protalix BioTherapeutics 1 Year Total Returns (Daily): -66.06% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 06, 2024 | -66.06% |
May 03, 2024 | -63.81% |
May 02, 2024 | -56.06% |
May 01, 2024 | -58.28% |
April 30, 2024 | -58.99% |
April 29, 2024 | -56.83% |
April 26, 2024 | -57.41% |
April 25, 2024 | -52.61% |
April 24, 2024 | -49.79% |
April 23, 2024 | -49.15% |
April 22, 2024 | -50.00% |
April 19, 2024 | -52.48% |
April 18, 2024 | -53.69% |
April 17, 2024 | -53.06% |
April 16, 2024 | -53.85% |
April 15, 2024 | -53.85% |
April 12, 2024 | -51.64% |
April 11, 2024 | -48.09% |
April 10, 2024 | -44.00% |
April 09, 2024 | -40.27% |
April 08, 2024 | -41.18% |
April 05, 2024 | -45.33% |
April 04, 2024 | -44.75% |
April 03, 2024 | -43.89% |
April 02, 2024 | -40.95% |
Date | Value |
---|---|
April 01, 2024 | -40.48% |
March 28, 2024 | -39.13% |
March 27, 2024 | -40.48% |
March 26, 2024 | -38.69% |
March 25, 2024 | -38.69% |
March 22, 2024 | -35.20% |
March 21, 2024 | -34.00% |
March 20, 2024 | -33.00% |
March 19, 2024 | -35.96% |
March 18, 2024 | -37.44% |
March 15, 2024 | -34.48% |
March 14, 2024 | -31.16% |
March 13, 2024 | -18.72% |
March 12, 2024 | -22.70% |
March 11, 2024 | -22.16% |
March 08, 2024 | -31.02% |
March 07, 2024 | -32.41% |
March 06, 2024 | -29.52% |
March 05, 2024 | -25.85% |
March 04, 2024 | -23.41% |
March 01, 2024 | -18.18% |
February 29, 2024 | -15.98% |
February 28, 2024 | -20.62% |
February 27, 2024 | -16.58% |
February 26, 2024 | -18.13% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-85.35%
Minimum
Feb 24 2022
189.7%
Maximum
May 04 2023
-0.77%
Average
-11.83%
Median
Jun 11 2019
1 Year Total Returns (Daily) Benchmarks
Agenus Inc | -58.76% |
InfuSystems Holdings Inc | -14.14% |
AIM ImmunoTech Inc | -14.20% |
Perspective Therapeutics Inc | 177.7% |
Armata Pharmaceuticals Inc | 69.59% |